http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022011391-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8bafcd9e91ed5c05ff22732a4081fe7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
filingDate 2021-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fa929dfbe3888422a0da08611c9ec09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7d165c6d674e4a37f255b229b6df957
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad1506fd166d8525a0098bdd39dd9c82
publicationDate 2022-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022011391-A1
titleOfInvention Salts and forms of a wee1 inhibitor
abstract The salt, such as adipate salt Form A, and freebase forms of Compound A are WEE1 inhibitors. Such salts and/or forms and freebase forms, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions, including conditions characterized by excessive cellular proliferation, such as breast cancer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023138362-A1
priorityDate 2020-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019173082-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID476840435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9822649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139467637
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396322
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID607
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID386823583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397150
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID386839340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40467203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID156794165
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID386823581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139482638
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037582
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396824
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID464
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15008962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139467635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395700

Total number of triples: 47.